Rocket Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Rocket Pharmaceuticals, Inc.‘s stocks are currently a part of 100 hedge funds’ portfolios, which represents 66.26% of the total amount of its stocks outstanding. This makes up a total of 45.15M shares of Rocket Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -40.48% or -30.71M shares fewer. As for the holding position changes, 40% (40) of current hedge fund investors increased the number of shares held, 25% (25) of current holders sold a part of the shares held, and 8% (8) closed the holdings completely. 10 hedge funds are new holders of Rocket Pharmaceuticals, Inc. stock in Q1 2023, it is 10% of total holders.
Hedge funds holding Rocket Pharmaceuticals (Q2 2018 – Q1 2023)
| Q2 2018 | 76 |
|---|---|
| Q3 2018 | 83 |
| Q4 2018 | 87 |
| Q1 2019 | 80 |
| Q2 2019 | 96 |
| Q3 2019 | 92 |
| Q4 2019 | 120 |
| Q1 2020 | 106 |
| Q2 2020 | 118 |
| Q3 2020 | 126 |
| Q4 2020 | 175 |
| Q1 2021 | 171 |
| Q2 2021 | 147 |
| Q3 2021 | 143 |
| Q4 2021 | 144 |
| Q1 2022 | 143 |
| Q2 2022 | 144 |
| Q3 2022 | 160 |
| Q4 2022 | 165 |
| Q1 2023 | 100 |
Hedge funds changes in Rocket Pharmaceuticals positions (Q2 2018 – Q1 2023)
| Q2 2018 | 34 | 19 | 14 | 13 | -4 |
|---|---|---|---|---|---|
| Q3 2018 | 19 | 23 | 20 | 12 | 9 |
| Q4 2018 | 20 | 36 | 13 | 15 | 3 |
| Q1 2019 | 8 | 34 | 17 | 14 | 7 |
| Q2 2019 | 23 | 45 | 15 | 5 | 8 |
| Q3 2019 | 13 | 40 | 20 | 17 | 2 |
| Q4 2019 | 36 | 41 | 27 | 8 | 8 |
| Q1 2020 | 14 | 42 | 29 | 28 | -7 |
| Q2 2020 | 27 | 48 | 24 | 15 | 4 |
| Q3 2020 | 21 | 41 | 44 | 12 | 8 |
| Q4 2020 | 58 | 52 | 49 | 9 | 7 |
| Q1 2021 | 26 | 75 | 51 | 29 | -10 |
| Q2 2021 | 9 | 66 | 49 | 32 | -9 |
| Q3 2021 | 11 | 54 | 49 | 15 | 14 |
| Q4 2021 | 25 | 57 | 43 | 22 | -3 |
| Q1 2022 | 23 | 55 | 43 | 25 | -3 |
| Q2 2022 | 26 | 58 | 38 | 21 | 1 |
| Q3 2022 | 30 | 64 | 40 | 14 | 12 |
| Q4 2022 | 32 | 78 | 39 | 24 | -8 |
| Q1 2023 | 10 | 40 | 25 | 8 | 17 |
Hedge funds changes in Rocket Pharmaceuticals stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 672,000 | 0 |
|---|---|---|
| Q3 2018 | 775,000 | 323,000 |
| Q4 2018 | 194,000 | 169,000 |
| Q1 2019 | 2,625,000 | 2,478,000 |
| Q2 2019 | 323,000 | 2,147,000 |
| Q3 2019 | 340,000 | 425,000 |
| Q4 2019 | 765,000 | 846,000 |
| Q1 2020 | 430,000 | 327,000 |
| Q2 2020 | 1,283,000 | 0 |
| Q3 2020 | 1,175,000 | 98,000 |
| Q4 2020 | 7,091,000 | 11,059,000 |
| Q1 2021 | 4,126,000 | 9,181,000 |
| Q2 2021 | 8,363,000 | 5,253,000 |
| Q3 2021 | 3,676,000 | 0 |
| Q4 2021 | 74,000 | 2,000 |
| Q1 2022 | 65,000 | 250,000 |
| Q2 2022 | 848,000 | 326,000 |
| Q3 2022 | 10,243,000 | 902,000 |
| Q4 2022 | 18,890,666 | 3,602,697 |
| Q1 2023 | 296,462,000 | 3,559,000 |